Trademark applications and grants for Sage Therapeutics Inc. Sage Therapeutics Inc has 40 trademark applications. The latest application filed is for "JOIZEMO"
Patent Application | Date |
---|---|
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS 20220220150 - 17/695033 Martinez Botella; Gabriel ;   et al. | 2022-07-14 |
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS 20220213137 - 17/694896 Martinez Botella; Gabriel ;   et al. | 2022-07-07 |
A CRYSTALLINE 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID 20220169674 - 17/396464 Watson; Paul Steven ;   et al. | 2022-06-02 |
METHODS OF TREATING EPILEPSY OR STATUS EPILEPTICUS 20220152050 - 17/592244 Reddy; Kiran ;   et al. | 2022-05-19 |
19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF 20220110950 - 17/560732 Martinez Botella; Gabriel ;   et al. | 2022-04-14 |
NCAGE Code | 6DBP9 | SAGE THERAPEUTICS, INC. |
CAGE Code | 6DBP9 | SAGE THERAPEUTICS, INC. |
S.A.M. Registration | 6DBP9 [968164959] | SAGE THERAPEUTICS, INC. |
SEC | 0001597553 | Sage Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.